BOSCHI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 13.646
AS - Asia 7.977
EU - Europa 5.160
SA - Sud America 1.345
Continente sconosciuto - Info sul continente non disponibili 401
AF - Africa 192
OC - Oceania 44
Totale 28.765
Nazione #
US - Stati Uniti d'America 13.236
SG - Singapore 2.995
CN - Cina 1.894
IT - Italia 1.456
BR - Brasile 1.046
VN - Vietnam 963
PL - Polonia 669
DE - Germania 651
HK - Hong Kong 633
GB - Regno Unito 487
UA - Ucraina 461
TR - Turchia 315
FI - Finlandia 302
SE - Svezia 249
FR - Francia 245
JP - Giappone 242
BD - Bangladesh 234
CA - Canada 200
IN - India 181
RU - Federazione Russa 166
MX - Messico 139
ID - Indonesia 129
AR - Argentina 106
NL - Olanda 97
ZA - Sudafrica 83
ES - Italia 60
IQ - Iraq 59
BE - Belgio 54
AT - Austria 51
EC - Ecuador 44
AU - Australia 43
UZ - Uzbekistan 42
VE - Venezuela 42
PK - Pakistan 38
CH - Svizzera 37
CO - Colombia 37
MY - Malesia 30
CZ - Repubblica Ceca 27
IR - Iran 27
PH - Filippine 26
LT - Lituania 25
CL - Cile 24
MA - Marocco 23
BG - Bulgaria 21
JM - Giamaica 20
SA - Arabia Saudita 20
TN - Tunisia 19
DK - Danimarca 16
HU - Ungheria 15
JO - Giordania 15
KE - Kenya 15
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
BO - Bolivia 13
KR - Corea 12
CR - Costa Rica 11
IE - Irlanda 11
PT - Portogallo 11
PY - Paraguay 11
DZ - Algeria 10
EG - Egitto 10
NP - Nepal 10
IL - Israele 9
UY - Uruguay 9
KG - Kirghizistan 8
LB - Libano 8
PE - Perù 7
RO - Romania 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
ET - Etiopia 6
HN - Honduras 6
KZ - Kazakistan 6
LV - Lettonia 6
BY - Bielorussia 5
GT - Guatemala 5
NO - Norvegia 5
PA - Panama 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
GY - Guiana 4
NI - Nicaragua 4
SV - El Salvador 4
AL - Albania 3
BB - Barbados 3
CG - Congo 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
MK - Macedonia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
BS - Bahamas 2
Totale 28.320
Città #
Singapore 1.880
Ashburn 1.537
San Jose 1.180
Woodbridge 846
Fairfield 784
Warsaw 657
Hong Kong 619
Santa Clara 616
Beijing 592
Chandler 572
Houston 557
Ann Arbor 511
Jacksonville 486
Council Bluffs 371
Ferrara 338
Wilmington 304
Ho Chi Minh City 292
Los Angeles 285
Seattle 281
New York 244
Tokyo 228
Cambridge 225
Hanoi 214
The Dalles 212
Dallas 211
Nanjing 191
Munich 184
Izmir 179
Addison 159
Milan 154
Lauterbourg 144
Princeton 144
Helsinki 125
São Paulo 118
Boardman 101
Buffalo 92
Shanghai 89
Dearborn 82
Dong Ket 81
Mexico City 81
Jakarta 78
Orem 73
London 71
Turku 71
Bologna 68
San Diego 68
Toronto 61
Rome 60
Montreal 59
Redwood City 57
Brooklyn 55
Da Nang 53
Nuremberg 53
Chicago 51
Chennai 49
Phoenix 49
Bremen 48
Denver 46
Frankfurt am Main 46
Tianjin 46
Nanchang 44
Brussels 43
Johannesburg 41
Shenyang 41
Boston 40
Atlanta 38
Hefei 37
Stockholm 37
Tashkent 36
Poplar 32
San Francisco 32
Vienna 32
Amsterdam 31
Changsha 31
Haiphong 30
Hebei 30
Moscow 30
Rio de Janeiro 30
Guangzhou 28
Falls Church 25
Baghdad 24
Legnaro 24
L’Aquila 24
Padova 23
Zurich 23
Biên Hòa 22
Jiaxing 22
Kunming 22
Augusta 21
Charlotte 21
Chengdu 21
Mumbai 21
Ankara 19
Belo Horizonte 19
Kuala Lumpur 19
Washington 19
Brasília 18
Dhaka 18
Naples 18
Columbus 17
Totale 18.231
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 530
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 398
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 342
Biodistribution of nanostructured lipid carriers: a tomographic study 337
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 337
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 328
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 308
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 294
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 291
A solvent-extraction module for cyclotron production of high-purity technetium-99m 284
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 284
LARAMED: A Laboratory for Radioisotopes of Medical Interest 278
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 277
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 260
YAP-(S)PET small animal scanner: Quantitative results 256
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 248
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 245
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 243
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 238
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 238
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 237
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 236
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 232
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 232
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 226
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 225
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 223
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 221
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 220
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 218
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 212
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 211
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 209
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 208
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 206
Extraction techniques of 99mTc from 100Mo Metal Target 205
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 202
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 200
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 198
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 198
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 198
Development of a β-spectrometer for 99gTc Activity Estimations 196
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 195
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 195
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 194
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 189
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 188
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 188
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 188
188W/188Re generator system and its therapeutic applicacions 187
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 187
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 184
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 182
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 182
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 180
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 180
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 179
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 179
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 179
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 178
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 177
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 176
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 175
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 175
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 174
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 173
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 172
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 171
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 171
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 169
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 166
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 164
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 163
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 162
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 162
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 161
Technetium complexes and radiopharmaceuticals with scorpionate ligands 161
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 160
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 156
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 156
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 155
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 154
Spark plasma sintering in manufacturing and recycling of ZnO targets for medical radioisotopes cyclotron-based production 153
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 153
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 153
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 153
Radioactive metal complexes comprising a tridentate complexing sequence 151
Advances in the automation technologies within LARAMED project 150
Radiopharmacy/Radiochemistry for Conventional Single-Photon Emitting and Therapeutic Radiopharmaceuticals 149
First in vivo imaging studies of cyclotron produced 99mTc-HMPAO 148
Development of a new class of Mn(II) complexes for MRI applications 147
Production of 47Sc with natural vanadium targets: results of the PASTA project 147
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 147
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 145
A remote-controlled automatic system for the labelling of lipiodol with Re-188 in the treatment of hepatocellular carcinoma 145
Recent Advances in Preclinical Studies of the Theranostic Agent [64Cu]CuCl2 143
Manganese-Loaded Liposomes: An In Vitro Study for Possible Diagnostic Application 143
Cyclotron production of manganese-52: a promising avenue for multimodal PET/MRI imaging 142
PASTA Project: Data Analysis 142
LABELLING OF SMALL MOLECULES WITH THE 99mTc-NITRIDO CORE (cap.15) 141
Totale 20.368
Categoria #
all - tutte 126.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 13.327
Totale 139.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.526 0 118 103 75 66 67 83 92 73 125 245 479
2022/20231.419 163 135 42 173 207 189 95 109 130 25 93 58
2023/20241.046 73 94 99 46 69 125 75 73 33 41 51 267
2024/20254.546 120 111 333 182 462 306 196 268 680 555 893 440
2025/202612.022 1.076 436 930 1.467 1.753 807 1.478 753 1.131 1.302 627 262
2026/2027847 369 478 0 0 0 0 0 0 0 0 0 0
Totale 28.765